TLN1 and neoplasm: By affecting the talin1 binding to TRIM21, BCKDK inhibited the talin1 ubiquitination and degradation, promoting the activation of the FAK/MAPK signaling pathways and the assembly of new FA structures, thereby enhancing the tumor cell migration.